It’s fairly likely that (URYL) could rapidly start onboarding new clients as the Decentralized Economy begins soaring towards an estimated $368Bn by 2027 at a 56.1% CAGR. (1)
Northern Shield is a powerful platform with little real competition to speak of.
Engineered to scale and meet the standards of even the strictest financial institutions, it has applications across some of the fastest-growing tech markets across the world:
- FinTech: Expected to reach a global market value of approximately $324Bn by 2026 at a 23.41% CAGR. (4)
- MedTech: The global MedTech market, or medical device market more specifically, is expected to grow from $471Bn in 2020 to reach $623Bn by 2026, at a 5% CAGR. (5)
- AgTech: The global AgTech market was valued at $17.4Bn in 2019. It’s projected to skyrocket to $41.1Bn by 2027 at a 12.1% CAGR. (6)
- HealthTech: In 2019, the global digital health market was worth an estimated $175Bn. Projections show this market could boom to roughly $660Bn by 2025 at an expected CAGR of almost 25%. (7)
But even as these market segments present a MASSIVE opportunity for potential growth, it’s important to remember that the company is just getting started.
Because TrueNorth is dedicated to building a decentralized economy beyond only financial applications…
And right now due to several potential catalysts, URYL needs to be your immediate focus.
No. 1 URYL Potential Breakout Catalyst - Low Float Profile
According to the OTC Markets' website, URYL has a low float.
The website reports this profile to have approximately 17.55Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility.
With so few shares available for trading, other potential catalysts (like big news) could spark a vertical move in the short-term.
No. 2 URYL Potential Breakout Catalyst - Oversold Leaning Technicals + Possible Healthy Reversal Short Term
As of 11:00AM EST Tuesday, Barchart was reporting this profile to have key oversold leaning technicals.
These technicals could be signaling a healthy reversal in the near term for URYL.
Here's the definition of a "reversal" from Investopedia:
"A reversal is a change in the price direction of an asset. A reversal can occur to the upside or downside. Following an uptrend, a reversal would be to the downside. Following a downtrend, a reversal would be to the upside. Reversals are based on overall price direction and are not typically based on one or two periods/bars on a chart."
Now, here are the technicals (as of 11:00AM EST Tuesday) that could signal URYL to be oversold and on the verge of a potential reversal.
- 14-Day Raw Stochastic: 18.96%
- 14-Day Williams %R: 81.04%
As the Raw Stochastic nears the 10% range and lower and the Williams %R nears the 90% range or higher, these technical indicators may also be viewed as oversold and undervalued.
Keep an eye on these technicals closely.
No. 3 URYL Potential Breakout Catalyst - The Closing Of A Game-Changing Acquisition
United Royale Group Holdings Corp. completed the acquisition of TrueNorth Quantum Inc.
Toronto, Ontario – TheNewswire - November 1, 2021 - TrueNorth Quantum Inc (formerly United Royale Group Holdings Corp. (OTC:URYL) is pleased to announce the closing of acquisition (the “Acquisition”) of TrueNorth Quantum Inc. ("TrueNorth"), the creator of the Northern Shield cloud platform for building institutional-grade decentralized applications for FinTech, MedTech, AgTech, and HealthTech. United Royale Group Holdings Corp. (the "Issuer") has completed a name change to TrueNorth Quantum Inc. which is pending regulatory approval and completion. On Friday, October 29, 2021, the Issuer acquired 100% of the issued and outstanding common shares of TrueNorth on the basis of 14 Issuer shares for every 1 common share outstanding of TrueNorth. The Acquisition was completed by the direct issuance of 9,053,338 common shares of the Issuer to Non-Canadian resident shareholders of TrueNorth and the issuance of 145,977,552 exchangeable shares (the “Exchangeable Shares”) of a wholly owned subsidiary of the Issuer. Each Exchangeable Share is exchangeable at this instance of the holder thereof, for 1 common share of the Issuer. All common shares of the Issuer issued under the Acquisition are subject to a 12 month hold period. Total number of issued common shares is 151,043,725.
URYL common shares are quoted on OTC Markets' OTCQB market.
Read the full article here.
No. 4 URYL Potential Breakout Catalyst - Explosive Chart History/Massive Upside Potential To Recent Highs
Take a quick look at URYL's 6-month chart: